We found two intronic variants with allele frequency <0.45 and 2 upstream variants within the TFBS of DCP1A, which is a biomarker used for gastric [85], colorectal [86], and hepatocellular cancer progression [87]. Here, DCP1A is linked to hepatocellular carcinoma.